AiVita Biomedical, Inc.
Biotechnology company · Irvine, California, United States
AiVita Biomedical, Inc. is a biotechnology company headquartered in Irvine, California, United States. Its earliest recorded incorporation is in 2016. The US FDA lists 1 medical device site registered to the company, with devices in general hospital, hematology and general and plastic surgery. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2022.
AiVita Biomedical at a glance
What does AiVita Biomedical do?
Medical specialties of its FDA-listed devices
Device types listed with the FDA
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $6 million sold (2022).
Where is AiVita Biomedical located?
Headquarters: Irvine, California, United States
- Irvine, CaliforniaAivita Biomedical, Inc. · FDA device site
Frequently asked questions about AiVita Biomedical
Where is AiVita Biomedical headquartered?
AiVita Biomedical, Inc. is headquartered in Irvine, California, United States.
What does AiVita Biomedical do?
AiVita Biomedical, Inc. is a biotechnology company. Its FDA-listed medical devices fall under general hospital, hematology and general and plastic surgery.
When was AiVita Biomedical founded?
The earliest incorporation on record for AiVita Biomedical, Inc. is in 2016, according to public company registers.
Similar companies
- Celestial Therapeutics Inc.Irvine, California, United States
- Tarsus Pharmaceuticals, Inc.Irvine, California, United States
- Cloudbreak Therapeutics LLCIrvine, California, United States
- Praxis Bioresearch IncIrvine, California, United States
- Nuravax, Inc.Irvine, California, United States
- Immunis, Inc.Irvine, California, United States
- AcuFocus, Inc.Irvine, California, United States
- PeproMene Bio, Inc.Irvine, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences